DE59108350D1 - Herstellung und Verwendung von Genbanken synthetischer menschlicher Antikörper ("synthetische Human-Anti-Körper-Bibliotheken) - Google Patents
Herstellung und Verwendung von Genbanken synthetischer menschlicher Antikörper ("synthetische Human-Anti-Körper-Bibliotheken)Info
- Publication number
- DE59108350D1 DE59108350D1 DE59108350T DE59108350T DE59108350D1 DE 59108350 D1 DE59108350 D1 DE 59108350D1 DE 59108350 T DE59108350 T DE 59108350T DE 59108350 T DE59108350 T DE 59108350T DE 59108350 D1 DE59108350 D1 DE 59108350D1
- Authority
- DE
- Germany
- Prior art keywords
- synthetic human
- libraries
- production
- gene banks
- human antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4002897A DE4002897A1 (de) | 1990-02-01 | 1990-02-01 | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
DE4003880A DE4003880A1 (de) | 1990-02-01 | 1990-02-09 | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
Publications (1)
Publication Number | Publication Date |
---|---|
DE59108350D1 true DE59108350D1 (de) | 1997-01-02 |
Family
ID=25889601
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE4002897A Withdrawn DE4002897A1 (de) | 1990-02-01 | 1990-02-01 | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
DE4003880A Withdrawn DE4003880A1 (de) | 1990-02-01 | 1990-02-09 | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
DE59108350T Expired - Lifetime DE59108350D1 (de) | 1990-02-01 | 1991-01-28 | Herstellung und Verwendung von Genbanken synthetischer menschlicher Antikörper ("synthetische Human-Anti-Körper-Bibliotheken) |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE4002897A Withdrawn DE4002897A1 (de) | 1990-02-01 | 1990-02-01 | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
DE4003880A Withdrawn DE4003880A1 (de) | 1990-02-01 | 1990-02-09 | Herstellung und verwendung von genbanken synthetischer menschlicher antikoerper ("synthetische human-antikoerper-bibliotheken") |
Country Status (13)
Country | Link |
---|---|
US (1) | US5840479A (de) |
EP (1) | EP0440146B1 (de) |
JP (1) | JPH04211395A (de) |
KR (1) | KR100221897B1 (de) |
AT (1) | ATE145427T1 (de) |
AU (1) | AU638535B2 (de) |
CA (1) | CA2035384C (de) |
DE (3) | DE4002897A1 (de) |
DK (1) | DK0440146T3 (de) |
ES (1) | ES2097157T3 (de) |
GR (1) | GR3022131T3 (de) |
IE (1) | IE75220B1 (de) |
PT (1) | PT96624B (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6916605B1 (en) | 1990-07-10 | 2005-07-12 | Medical Research Council | Methods for producing members of specific binding pairs |
GB9015198D0 (en) * | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
US7063943B1 (en) | 1990-07-10 | 2006-06-20 | Cambridge Antibody Technology | Methods for producing members of specific binding pairs |
WO1993002190A1 (en) * | 1991-07-15 | 1993-02-04 | The Wellcome Foundation Limited | Production of antibodies |
PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
US5316922A (en) * | 1992-04-15 | 1994-05-31 | The United States Of America As Represented By Department Of Health And Human Services | Method for indentifying and expressing proteins that recognize and adhere to specific probes |
CA2222879A1 (en) * | 1995-06-02 | 1996-12-05 | M&E Biotech A/S | A method for identification of biologically active peptides and nucleic acids |
US20010053523A1 (en) * | 1995-06-02 | 2001-12-20 | M&E Biotech A/S. | Method for identification of biologically active peptides and nucleic acids |
US6706484B1 (en) | 1995-08-18 | 2004-03-16 | Morphosys Ag | Protein/(poly)peptide libraries |
ES2176484T3 (es) * | 1995-08-18 | 2002-12-01 | Morphosys Ag | Bancos de proteinas/(poli)peptidos. |
DE69722176T2 (de) | 1996-01-23 | 2004-03-18 | The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto | Verfahren zur suche nach transdominanten effektorpeptiden und rna-molekülen |
US6365344B1 (en) | 1996-01-23 | 2002-04-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US7087420B1 (en) | 1997-07-17 | 2006-08-08 | Cambia | Microbial β-glucuronidase genes, gene products and uses thereof |
US6391547B1 (en) * | 1997-09-09 | 2002-05-21 | Center For The Application Of Molecular Biology To International Agriculture | Microbial β-glucuronidase genes, gene products and uses thereof |
US6911429B2 (en) * | 1999-04-01 | 2005-06-28 | Transition Therapeutics Inc. | Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
US6864235B1 (en) * | 1999-04-01 | 2005-03-08 | Eva A. Turley | Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
IL130225A0 (en) | 1999-05-31 | 2000-06-01 | Yissum Res Dev Co | Novel uses of antibodies against ache and peptides thereof |
ES2393535T3 (es) * | 2000-04-17 | 2012-12-26 | Dyax Corp. | Nuevos métodos para construir bibliotecas de paquetes genéticos que presentan de forma colectiva los miembros de una familia diversa de péptidos, polipéptidos o proteínas |
US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
US20020110843A1 (en) * | 2000-05-12 | 2002-08-15 | Dumas David P. | Compositions and methods for epitope mapping |
AU2002249854B2 (en) | 2000-12-18 | 2007-09-20 | Dyax Corp. | Focused libraries of genetic packages |
US20040259783A1 (en) * | 2001-11-09 | 2004-12-23 | Tony Cruz | Pharmaceutical compositions of marine sponge microciona prolifera |
DE60232688D1 (de) | 2001-11-20 | 2009-07-30 | Univ Duke | Grenzflächen-biomaterialien |
KR100604037B1 (ko) * | 2002-08-02 | 2006-07-24 | 주식회사유한양행 | 항체 경쇄 카파 발현벡터 |
KR100528772B1 (ko) * | 2002-08-02 | 2005-11-15 | 주식회사유한양행 | 항체 경쇄 람다 발현벡터 |
WO2004013278A2 (en) * | 2002-08-02 | 2004-02-12 | Yuhan Corporation | Expression vectors |
KR100604038B1 (ko) * | 2002-08-02 | 2006-07-24 | 주식회사유한양행 | 항체 중쇄 발현벡터 |
US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
CN100406554C (zh) * | 2003-03-28 | 2008-07-30 | 广州医学院 | 一种含人源导向溶栓抗体基因的大肠杆菌及其分泌产物 |
EP2255832A3 (de) | 2004-06-16 | 2011-02-09 | Affinergy, Inc. | Grenzflächenbiomaterialien zur Förderung der Anhaftung von Zielanalyten |
CN101528921B (zh) | 2006-01-20 | 2013-11-20 | 细胞信号技术有限公司 | 人非小细胞肺癌中的易位和突变的ros激酶 |
US20120208824A1 (en) | 2006-01-20 | 2012-08-16 | Cell Signaling Technology, Inc. | ROS Kinase in Lung Cancer |
WO2009051846A2 (en) | 2007-10-18 | 2009-04-23 | Cell Signaling Technology, Inc. | Translocation and mutant ros kinase in human non-small cell lung carcinoma |
WO2007092777A2 (en) * | 2006-02-02 | 2007-08-16 | Wyeth | Cloning, characterization, and application of tnfrsf19 in neurological disorders |
EP2450437B1 (de) | 2006-04-14 | 2017-05-17 | Cell Signaling Technology, Inc. | Gendefekte und Mutante ALK-Kinase in festen menschlichen Tumoren |
US20090252745A1 (en) * | 2006-09-15 | 2009-10-08 | Duke University | Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis |
DK3124497T3 (da) | 2007-09-14 | 2020-05-11 | Adimab Llc | Rationelt designede syntetiske antistofbiblioteker og anvendelser deraf |
US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
US9873957B2 (en) | 2008-03-13 | 2018-01-23 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR3 designs |
JP5780951B2 (ja) | 2008-04-24 | 2015-09-16 | ダイアックス コーポレーション | 新規のhccdr1、cdr2、およびcdr3設計、ならびに新規のlccdr1、cdr2、およびcdr3設計を含む、遺伝子パッケージのライブラリ |
CN101768213B (zh) | 2008-12-30 | 2012-05-30 | 中国科学院遗传与发育生物学研究所 | 一种与植物分蘖数目相关的蛋白及其编码基因与应用 |
EP2881402B1 (de) | 2009-02-12 | 2017-05-10 | Cell Signaling Technology, Inc. | Expression mutanter ROS bei menschlichem Leberkrebs |
CN101817879A (zh) | 2009-02-26 | 2010-09-01 | 中国科学院遗传与发育生物学研究所 | 金属硫蛋白及其编码基因与应用 |
JP5804521B2 (ja) | 2009-05-29 | 2015-11-04 | モルフォシス・アー・ゲー | コレクション及びその使用方法 |
WO2011032181A2 (en) * | 2009-09-14 | 2011-03-17 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr3 designs |
EP2518725A4 (de) | 2009-12-22 | 2014-10-08 | Panasonic Corp | Optische plattenvorrichtung, verfahren zur steuerung einer optischen platte und integrierte schaltung |
JP6266343B2 (ja) | 2010-07-16 | 2018-01-24 | アディマブ, エルエルシー | 抗体ライブラリー |
US20120101108A1 (en) | 2010-08-06 | 2012-04-26 | Cell Signaling Technology, Inc. | Anaplastic Lymphoma Kinase In Kidney Cancer |
MX353795B (es) | 2010-11-19 | 2018-01-30 | Morphosys Ag | Coleccion y metodos para su uso. |
WO2013158859A1 (en) | 2012-04-18 | 2013-10-24 | Cell Signaling Technology, Inc. | Egfr and ros1 in cancer |
BR112020003622A2 (pt) | 2017-08-21 | 2020-09-01 | Adagene Inc. | cadeia pesada de anticorpo, anticorpo, bibliotecas, kit, método de preparo de uma biblioteca, método de produção de uma biblioteca de anticorpos, fago, método de geração de um anticorpo biespecífico e anticorpo biespecífico |
JP7324744B2 (ja) | 2017-08-21 | 2023-08-10 | アダジーン インコーポレイテッド | ダイナミックヒト抗体軽鎖ライブラリー |
CN116390945A (zh) * | 2020-09-24 | 2023-07-04 | 博德研究所 | 无细胞抗体工程化平台和针对SARS-CoV-2的中和抗体 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3852304T3 (de) * | 1987-03-02 | 1999-07-01 | Enzon Lab Inc | Organismus als Träger für "Single Chain Antibody Domain (SCAD)". |
-
1990
- 1990-02-01 DE DE4002897A patent/DE4002897A1/de not_active Withdrawn
- 1990-02-09 DE DE4003880A patent/DE4003880A1/de not_active Withdrawn
-
1991
- 1991-01-28 DK DK91101094.0T patent/DK0440146T3/da active
- 1991-01-28 DE DE59108350T patent/DE59108350D1/de not_active Expired - Lifetime
- 1991-01-28 ES ES91101094T patent/ES2097157T3/es not_active Expired - Lifetime
- 1991-01-28 AT AT91101094T patent/ATE145427T1/de not_active IP Right Cessation
- 1991-01-28 EP EP91101094A patent/EP0440146B1/de not_active Expired - Lifetime
- 1991-01-31 PT PT96624A patent/PT96624B/pt not_active IP Right Cessation
- 1991-01-31 CA CA002035384A patent/CA2035384C/en not_active Expired - Lifetime
- 1991-01-31 AU AU70115/91A patent/AU638535B2/en not_active Expired
- 1991-01-31 IE IE33691A patent/IE75220B1/en not_active IP Right Cessation
- 1991-02-01 JP JP3032216A patent/JPH04211395A/ja active Pending
- 1991-02-01 KR KR1019910001732A patent/KR100221897B1/ko not_active IP Right Cessation
-
1994
- 1994-12-02 US US08/353,372 patent/US5840479A/en not_active Expired - Lifetime
-
1996
- 1996-12-20 GR GR960403569T patent/GR3022131T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE4003880A1 (de) | 1991-08-14 |
IE910336A1 (en) | 1991-08-14 |
KR910021474A (ko) | 1991-12-20 |
EP0440146B1 (de) | 1996-11-20 |
PT96624A (pt) | 1991-11-29 |
AU7011591A (en) | 1991-08-08 |
US5840479A (en) | 1998-11-24 |
JPH04211395A (ja) | 1992-08-03 |
GR3022131T3 (en) | 1997-03-31 |
DK0440146T3 (da) | 1997-03-10 |
EP0440146A3 (en) | 1992-07-15 |
ES2097157T3 (es) | 1997-04-01 |
AU638535B2 (en) | 1993-07-01 |
CA2035384A1 (en) | 1991-08-02 |
DE4002897A1 (de) | 1991-08-08 |
CA2035384C (en) | 2003-07-08 |
EP0440146A2 (de) | 1991-08-07 |
IE75220B1 (en) | 1997-08-27 |
KR100221897B1 (ko) | 1999-10-01 |
ATE145427T1 (de) | 1996-12-15 |
PT96624B (pt) | 1998-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59108350D1 (de) | Herstellung und Verwendung von Genbanken synthetischer menschlicher Antikörper ("synthetische Human-Anti-Körper-Bibliotheken) | |
DE69130647D1 (de) | Verfahren zur herstellung von oligonukleotiden mit regellosen codonen | |
DE69412767T2 (de) | Fluormodifiziertes Silikon, Verfahren zu seiner Herstellung und dieses enthaltende Kosmetika | |
DE69610433D1 (de) | Verfahren zur herstellung von halogenierten alkanen | |
ATE316137T1 (de) | Humanisierte antikörper gegen den epidermalen wachstumsfaktorrezeptor | |
DE69105236D1 (de) | Tetrafluorethylen-Copolymer und Verfahren zu seiner Herstellung. | |
DE60237778D1 (de) | Antikörper gegen kdr, deren herstellung und verwendungen | |
DE69614940T2 (de) | Ethylen-Copolymerkautschukzusammensetzung, vulkanisierbare Kautschukzusammensetzung, die den Copolymerkautschuk enthält und Verfahren zur Herstellung von Copolymerkautschuk | |
RU2012102323A (ru) | Способ лечения ревматоидного артрита посредством лекарственного препарата на основе выделенного человеческого антитела или его антигенсвязывающего фрагмента | |
ATE215335T1 (de) | Verbesserter reinigungsbausch und verfahren zu dessen herstellung | |
ATE232902T1 (de) | Anti-egfr einkettige fvs und anti-egfr antikoerper | |
DE69115129T2 (de) | Zusammensetzungen von kubischer Perowskit-Kristallstruktur, Verfahren zu ihrer Herstellung und Produkte daraus. | |
DE69124387T2 (de) | Rahmenbau-mutierte antikörper und ihre herstellung | |
DE69600024D1 (de) | Kosmetisches Mittel enthaltend ein filmbildendes Polymer, Verfahren zur Herstellung desselben und Verwendung | |
ATE166883T1 (de) | Monoklonale antikörper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung | |
DE3584705D1 (de) | Endotoxin von gram-negativ-bakterien blockierende monoklonale antikoerper, zellen die diese produzieren, zubereitungen die diese enthalten und verfahren zur herstellung dieser produkte. | |
DE68907735T2 (de) | Genfragmente, die die variable Region eines Anti-HIV-Antikörpers codieren, von diesen exprimierte chimäre Anti-HIV-Antikörper und Verfahren zu deren Herstellung. | |
DE69109387T2 (de) | Ethylencopolymer und Verfahren zu seiner Herstellung. | |
DE69604030D1 (de) | Propylenpolymer, Verfahren zu seiner Herstellung, Verwendung desselben und Objekte daraus | |
ATE79121T1 (de) | Iodierte polymere, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel. | |
DE3854267T2 (de) | HIV-spezifische monoklonale Antikörper und Hybridome zu ihrer Herstellung. | |
CY1107785T1 (el) | Χρηση του βασιλιξιμαμπ στη θεραπεια της ρευματοειδους αρθριτιδας ´η νοσων του δερματος | |
DE59102499D1 (de) | Verfahren zur Behandlung von Spaltgasen bei der Gewinnung von Ethylen. | |
ATE92102T1 (de) | Genfragmente, die die variable region eines anti- hiv-antikoerpers codieren, von diesen exprimierte chimaere anti-hiv-antikoerper und verfahren zu deren herstellung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: BEHRING DIAGNOSTICS GMBH, 35041 MARBURG, DE |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: DADE BEHRING MARBURG GMBH, 35041 MARBURG, DE |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, , DE |